S. Majocchi

Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies

Z. Johnson, W. Ferlin, N. Fischer, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity

W. Ferlin, N. Fischer, P. Malinge, 2018, Antibodies.

MAR-Mediated Dystrophin Expression in Mesoangioblasts for Duchenne Muscular Dystrophy Cell Therapy

N. Mermod, G. Cossu, Francesco Saverio Tedesco, 2015 .

Transcription Factor CTF1 Acts as a Chromatin Domain Boundary That Shields Human Telomeric Genes from Silencing

J. Beckmann, N. Mermod, D. Martinet, 2009, Molecular and Cellular Biology.

Epigenetic regulatory elements associate with specific histone modifications to prevent silencing of telomeric genes

N. Mermod, Elena Aritonovska, S. Majocchi, 2013, Nucleic acids research.

Abstract 546: Selectively targeting CD47 with bispecific antibody to efficiently eliminate mesothelin-positive solid tumors

L. Shang, V. Buatois, W. Ferlin, 2019, Clinical Research (Excluding Clinical Trials).

MAR‐Mediated transgene integration into permissive chromatin and increased expression by recombination pathway engineering

I. Xenarios, N. Mermod, C. Iseli, 2016, Biotechnology and bioengineering.

In situ evaluation of single-cell lysis by cytosol extraction observation through fluorescence decay and dielectrophoretic trapping time

P. Renaud, N. Mermod, Guillaume Mernier, 2012 .